Hold Up, HPV: How Therapeutic Vaccines Can Help Curb Cervical Premalignancies
A therapeutic HPV vaccine showed remarkable benefits for patients with high-grade cervical precancers.
Progress Against Cancer
A therapeutic HPV vaccine showed remarkable benefits for patients with high-grade cervical precancers.
At the 2024 San Antonio Breast Cancer Symposium, researchers discussed clinical trials for vaccines and other ways to prevent breast cancer.
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
Our annual Experts Forecast offers insights from AACR President-Elect Lillian Siu, John E. Dick, Regina Barzilay, Vinod Balachandran, and Scarlett Lin Gomez.
Androgen deprivation therapy, a common prostate cancer treatment, may increase cognitive difficulties.
Shorter courses of more intense radiation therapy mean fewer visits and less cost for patients. Studies show abbreviated treatments are just as effective as longer courses.
With targeted therapy options available for a growing number of cancer types, biomarker testing is making a difference for more people with solid cancers.
Findings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
This month, the editors of the AACR journals highlighted studies about the gut microbiome in lung cancer, modeling the risk of adenoma progression, and more.
Researchers at the 2024 San Antonio Breast Cancer Symposium discussed considerations for treating and managing of early-onset breast cancer.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now